PHARMALABEL
Timeline
44 events since 1986Board
Capital
Filings
Financial
End
19901995200020052010201520202025
2021
Merger: absorbed by SL CORPORATEDissolution of the company · Dissolved without liquidation · SL CORPORATE holds all the shares · General meeting of 30-06-20215 points ▸
- General meeting, 30-06-2021
- Accounting effect, 01-01-2021
- SL CORPORATE holds all the shares
- Net-asset statement, 31-12-2020
- Power of attorney, Delberghe, Florence (medewerkster van notaris christophe blindeman)
- The deed holds 6 more points.
Merger proposal: to be absorbed by SL CORPORATE3 points ▸
- 84,568 shares
- 4,034 shares
- Accounting effect, 01-01-2021
- The deed holds 3 more points.
Annual accounts 2020 filed PDFfull format · 93 days before the deadline
2020
- Board meeting, 03-08-2020
- Director appointment, Jerome Dhondt (managing director)
Annual accounts 2019 filed PDFfull format · 25 days late
2019
Back to profit net €4,277 The net result is €4,277, after one loss-making year.
Equity above €2m equity €2.6m ▲161% Equity rises from €997,980 to €2.6m.
Annual accounts 2018 filed PDFfull format · 29 days late
2018
Annual accounts 2017 filed PDFfull format · 29 days late
2017
Annual accounts 2016 filed PDFfull format · 29 days late
2016
Annual accounts 2015 filed PDFabbreviated format · 23 days late
2015
Highest result from 2006 to 2020 net €511,723 ▲3,870% The net result of €511,723 is the highest of those years.
Liquidity more than 16 times current ratio 1.21 The current ratio rises from 0.07 to 1.21. Short-term debt falls from €528,613 to €43,053.
Equity above €500,000 equity €982,932 ▲109% After 4 profitable years in a row, equity reaches €982,932.
Annual accounts 2014 filed PDFabbreviated format · 24 days late
2014
Annual accounts 2013 filed PDFabbreviated format · 28 days late
2013
Annual accounts 2012 filed PDFabbreviated format · 29 days late
2012
Back to profit net €49,872 The net result is €49,872, after 5 loss-making years.
Annual accounts 2011 filed PDFabbreviated format · 29 days late
2011
Weakest financial year net -€28,142 The net result drops to -€28,142, the lowest from 2006 to 2020.
Annual accounts 2010 filed PDFabbreviated format · 16 days before the deadline
2010
Annual accounts 2009 filed PDFabbreviated format · 31 days late
2009
Annual accounts 2008 filed PDFabbreviated format · 17 days late
2008
Annual accounts 2007 filed PDFabbreviated format · 27 days late
2007
Annual accounts 2006 filed PDFabbreviated format · 23 days late
2006
Annual accounts 2005 filed PDFabbreviated format
2005
Annual accounts 2004 filed PDFabbreviated format
2004
Annual accounts 2003 filed PDFabbreviated format
2003
Annual accounts 2002 filed PDFabbreviated format
2002
Annual accounts 2001 filed PDFabbreviated format
Annual accounts 2000 filed PDFabbreviated format
2000
Annual accounts 1999 filed PDFabbreviated format
Annual accounts 1998 filed PDFabbreviated format
1998
Annual accounts 1997 filed PDFabbreviated format
1996
Annual accounts 1995 filed PDFabbreviated format
1995
Annual accounts 1994 filed PDFabbreviated format
1994
Annual accounts 1993 filed PDFabbreviated format
1993
Annual accounts 1992 filed PDFabbreviated format
1992
Annual accounts 1991 filed PDFabbreviated format
Annual accounts 1990 filed PDFabbreviated format
1990
Annual accounts 1989 filed PDFabbreviated format
1989
Annual accounts 1988 filed PDFabbreviated format
1988
Annual accounts 1987 filed PDFabbreviated format
1986
Incorporation 20 publications in the Belgian Official Gazette, the last on 01-09-2021
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
PHARMALABEL has filed 33 sets of annual accounts, the latest for financial year 2020.1 In 2021 the company was absorbed by merger into SL CORPORATE.2